新学期临近，对于许多杭州的初二女生和家长来说，这个寒假除了走亲访友、体育锻炼、参与实践 等，还多了一件关乎健康的"大事"——接种国家免疫规划提供的免费双价HPV疫苗。 "很多家长关心为什么要这么早给孩子接种？"专家提到，研究显示，我国女性HPV感染的第一个高 峰为17—24岁，且近年来宫颈癌发病日益年轻化，最小发病年龄已低至15岁。因此在感染高峰到来前接 种疫苗建立保护屏障至关重要，"9—14岁女孩仅需接种两剂次，就能达到很好的保护效果，实现'早接 种、早保护'。" 记者了解到，除了国家免疫规划提供的免费双价HPV疫苗外，适龄女生也可自愿、自费选择其他不 同品牌、不同价型的HPV疫苗进行替代接种。 对于想要选择九价疫苗的家长和孩子来说，眼下也是一个不错的窗口期。目前，上城区、拱墅区、 西湖区、萧山区、余杭区、富阳区、桐庐县、建德市、淳安县等地正在开展HPV疫苗接种惠民活动，9- 14岁女生全程接种两剂次（按0、6月接种）进口九价HPV疫苗可享"减免1剂次疫苗费用"；预计临安区 和钱塘区将于3月1日开始。家长可选择居住地或学校所在的社区卫生服务中心预防接种门诊进行接种， 建议提前通过浙里办App上的"浙里接种" ...

转自：扬子晚报 记者了解到，自2025年11月10日起，HPV疫苗正式纳入国家免疫规划，江苏省同步落地实施相关政策， 为符合条件的适龄女孩提供免费接种服务。 为什么要将HPV疫苗纳入国家免疫规划？为何国家免疫规划HPV疫苗的目标人群为13周岁女孩？记者请 教了江苏省疾病预防控制中心免规所专家。 图源 视觉中国 1.为什么要将HPV疫苗纳入国家免疫规划？ 宫颈癌是女性生殖系统最常见的恶性肿瘤之一。及时接种HPV疫苗能够有效地降低宫颈癌的发生风险。 经国务院同意，决定自2025年11月10日起，在现行国家免疫规划疫苗基础上，将HPV疫苗纳入国家免疫 规划，组织各地为2011年11月10日以后出生的满13周岁女孩免费接种2剂次双价HPV疫苗（间隔6个 月）。 2.为何国家免疫规划HPV疫苗的目标人群为13周岁女孩？ HPV主要通过性行为感染，在发生性行为年龄之前进行HPV疫苗接种，可以获得更好的保护效果，最大 限度发挥疫苗预防HPV感染的作用。 相关研究表明，9—14岁女孩接种HPV疫苗产生的抗体水平，是15岁以上人群的2倍以上。接种HPV疫苗 可以有效预防70%以上的宫颈癌发生，同时也可以降低因感染HPV导致的其 ...

Core Viewpoint - The introduction of free HPV vaccines in Henan province aims to protect women's health by providing free vaccinations to eligible girls, highlighting the government's commitment to public health and social equity [1][2]. Group 1: Vaccine Introduction - The first batch of 20,000 doses of HPV vaccine has arrived in Zhengzhou, with distribution to local health centers starting immediately [1]. - The HPV vaccine will be included in the national immunization program starting from November 10, 2025, for girls born after November 10, 2011, who are at least 13 years old [1]. Group 2: Vaccine Safety and Efficacy - HPV vaccines have been administered over 1 billion times globally, demonstrating good safety profiles with common mild side effects [2]. - The optimal time for vaccination is around age 13, as it generates a stronger immune response, providing over 90% protection against HPV infections [2]. Group 3: Vaccination Details - Eligible girls must receive two doses of the vaccine, spaced six months apart, ideally completed within 12 months [5]. - Vaccination can be done at local community health service centers, and parental consent is required before the procedure [6]. Group 4: Vaccine Types and Options - The free vaccine provided is a bivalent HPV vaccine targeting types 16 and 18, which are responsible for approximately 70% of cervical cancer cases [4]. - There are also self-paid options available, including quadrivalent and nonavalent vaccines, which cover additional HPV types [7][8].

2025年11月10日起，我国在现行国家免疫规划疫苗基础上，将HPV疫苗纳入国家免疫规划。此前，本市 以落实2025年民生实事项目的方式，为2025年9月新入学的初一在校女生免费接种HPV疫苗。针对两项 政策如何衔接的问题，市疾控局表示，2025年9月新入学的初一在校女生，如已接种本市民生实事HPV 疫苗第1剂，可继续使用该疫苗完成全程接种。目前第1剂接种已结束。未接种过民生实事疫苗且符合国 家免疫规划接种条件的适龄女生，可选择国家免疫规划HPV疫苗进行接种。 本报讯（记者 孙乐琪）市疾控局昨天介绍，本市已全面启动适龄女生国家免疫规划HPV（人乳头瘤病 毒）疫苗接种，为满13周岁女生免费接种HPV疫苗。 市疾控局介绍，2011年11月10日以后出生的满13周岁女孩可免费接种2剂次双价HPV疫苗，2剂之间的接 种间隔为6个月。如果受种者未按照常规免疫程序完成2剂次疫苗接种，应在18岁之前尽早补齐2剂次。 第2剂与第1剂接种间隔6个月，间隔期最好不要超过一年。 适龄女生可根据所在学校安排，参加校内集中接种，也可通过拨打预防接种门诊电话、现场登记、"京 通"小程序、"首都疫苗服务" App等方式预约。预防接种门诊信 ...

Core Viewpoint - The Chinese government has announced the inclusion of the HPV vaccine in the national immunization program, aiming to reduce the burden of cervical cancer and promote public health [3] Group 1: Policy Announcement - The National Health Commission, along with six other departments, issued a notification regarding the inclusion of the HPV vaccine in the national immunization program [3] - Starting from November 10, 2025, girls born after November 10, 2011, who are at least 13 years old will receive two doses of the bivalent HPV vaccine for free [3] Group 2: Health Impact - This initiative is a significant step towards reducing the family burden associated with cervical cancer and other diseases caused by HPV [3] - The program reflects a national commitment to advancing public health and reducing disease incidence [3]

Group 1 - The core point of the article is that the HPV vaccine has been officially included in the national immunization program, allowing eligible girls to receive free vaccination services [3][4]. Group 2 - The target population for the HPV vaccine includes girls who are 13 years old and above, specifically those born after November 10, 2011 [4]. - Eligible individuals can receive two doses of the bivalent HPV vaccine for free, with the second dose administered six months after the first, and the interval should not exceed one year [5]. - The vaccination can be administered simultaneously with other vaccines at different injection sites [5]. Group 3 - Important considerations for vaccination include the requirement for a guardian to accompany the child, bringing identification documents, and monitoring for 30 minutes post-vaccination for any adverse reactions [5].

Core Points - The National Health Commission and six other departments announced the inclusion of the HPV vaccine in the national immunization program starting November 10, 2025, providing free vaccinations for girls born after November 10, 2011, who are at least 13 weeks old [1] - Cervical cancer is a common malignant tumor among women, posing significant health risks, and the government has initiated a plan to accelerate the elimination of cervical cancer from 2023 to 2030 [1] - Currently, 18 provinces have implemented policies to provide free HPV vaccinations or subsidies for eligible girls, laying a practical foundation for the national inclusion of the HPV vaccine [1]

Group 1 - The Chinese government has decided to include the HPV vaccine in the national immunization program starting from November 10, 2025, targeting girls born after November 10, 2011, who are 13 years old, providing them with two doses of the bivalent HPV vaccine for free [1][2] - The decision is based on the rising incidence and mortality rates of cervical cancer in China, particularly among younger populations, highlighting the importance of HPV vaccination in preventing high-risk HPV infections and reducing the occurrence of cervical cancer [1][2] - The World Health Organization recommends vaccinating girls aged 9 to 14 years before they become sexually active, while China has set the target group for free vaccination at 13 years old, considering the optimal balance of protection effectiveness, cost-effectiveness, and operational feasibility [1][2] Group 2 - The notification emphasizes the need for monitoring the production and supply of HPV vaccines, with various departments responsible for ensuring stable production and addressing challenges faced by manufacturers [2] - China has a total annual production capacity of 55 million doses of the bivalent HPV vaccine from two domestic manufacturers, which is sufficient to meet market demand, and these vaccines have received pre-certification from the World Health Organization [2] - The first domestically produced nine-valent HPV vaccine was approved for market use in mid-2023, marking it as the second nine-valent HPV vaccine globally and breaking the long-standing market monopoly held by foreign products [2]

Group 1 - The inclusion of the HPV vaccine in the national immunization program is a significant step towards reducing the burden of cervical cancer in China and promoting public health [4][5] - The target population for the free vaccination program is girls aged 13 years and older, who will receive two doses of the bivalent HPV vaccine, with a six-month interval between doses [4] - In 2022, approximately 151,000 new cases of cervical cancer were reported in China, with around 56,000 deaths, highlighting the urgency of preventive measures [4] Group 2 - The domestic production capacity for the bivalent HPV vaccine is 55 million doses annually, sufficient to meet market demand, and both manufacturers have received pre-certification from the World Health Organization [5] - The initiative to include the HPV vaccine in the national immunization program represents a new phase in China's immunization efforts, aiming to enhance health equity and accessibility [5] - The collaboration among various departments is essential to ensure the smooth implementation of the vaccination policy, which aims to protect more girls from cervical cancer [5]

Core Points - The Chinese government has committed to providing free HPV vaccinations for girls aged 13 and above, starting from November 10, 2025, as part of the national immunization program [1][2] - This initiative aims to reduce the financial burden of cervical cancer on families and promote public health [1] - Cervical cancer is a significant health threat to women, with approximately 151,000 new cases and 56,000 deaths reported in China in 2022 [1] Group 1 - The policy will allow eligible girls to receive two doses of the bivalent HPV vaccine for free, with a six-month interval between doses [2] - The initiative is designed to improve vaccination rates and ensure equitable access across different regions and income groups [2] - The decision to target 13-year-old girls is based on considerations of protection effectiveness, cost-effectiveness, and operational feasibility [2] Group 2 - The domestic production capacity for the bivalent HPV vaccine is 55 million doses annually, sufficient to meet market demand [3] - The inclusion of the HPV vaccine in the national immunization program marks a new phase in China's immunization efforts [3] - The initiative reflects China's commitment to women's health and aims to contribute to global health equity [3]